Susanne Beck
-
- Peptidase Inhibition and Analysis 3
- PARP inhibition in cancer therapy 3
-
- Cancer Genomics and Diagnostics 4
-
- Multiple Myeloma Research and Treatments 5
-
- Head and Neck Cancer Studies 3
-
- DNA Repair Mechanisms 3
- Protein Degradation and Inhibitors 3
-
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Jan BudcziesAlbrecht StenzingerKlaus KluckDaniel KazdalPeter SchirmacherMichael MenzelMichael AllgäuerConstantin Schwab
- Cited by
- OncologyCancer ResearchHematology
In The Last Decade
Susanne Beck
17 papers receiving 234 citations
Hit Papers
Peers
Comparison fields: 5 of 51
- Oncology 123
- Cancer Research 57
- Hematology 40
- Otorhinolaryngology 11
- Molecular Biology 115
Countries citing papers authored by Susanne Beck
This map shows the geographic impact of Susanne Beck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susanne Beck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susanne Beck more than expected).
Fields of papers citing papers by Susanne Beck
This network shows the impact of papers produced by Susanne Beck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susanne Beck. The network helps show where Susanne Beck may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Susanne Beck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 0 | |
| 5 | Tumour mutational burden: clinical utility, challenges and emerging improvementsbreakdown → | 2024 | 47 |
| 6 | 2023 | 6 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 17 | |
| 9 | 2023 | 8 | |
| 10 | 2022 | 49 | |
| 11 | 2022 | 1 | |
| 12 | 2022 | 21 | |
| 13 | 2021 | 29 | |
| 14 | 2020 | 8 | |
| 15 | 2019 | 6 | |
| 16 | 2018 | 32 | |
| 17 | 2018 | 1 | |
| 18 | 2016 | 2 | |
| 19 | 2016 | 1 |
About Susanne Beck
Susanne Beck is a scholar working on Otorhinolaryngology, Hematology and Oncology, having authored 19 papers that have together received 236 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (5 papers), Cancer Genomics and Diagnostics (4 papers), Lung Cancer Treatments and Mutations (4 papers), DNA Repair Mechanisms (3 papers), Protein Degradation and Inhibitors (3 papers), Peptidase Inhibition and Analysis (3 papers), Head and Neck Cancer Studies (3 papers) and PARP inhibition in cancer therapy (3 papers). The work is most often cited by research in Oncology (123 citations), Cancer Research (57 citations) and Hematology (40 citations). Susanne Beck has collaborated with scholars based in Germany, France and Czechia. Frequent co-authors include Jan Budczies, Albrecht Stenzinger, Klaus Kluck, Daniel Kazdal, Peter Schirmacher, Michael Menzel, Michael Allgäuer, Constantin Schwab, Dirk Hose and Wilko Weichert. Their work appears in journals such as Journal of Clinical Oncology, Blood and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.